510(k) Report

510(k) · Cleared

Cleared

Architect Active B-12 (Holotranscobalamin)

K112443510(k) TraditionalCleared Dec 19, 2011117-day reviewClass II21 CFR 862.1810

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Axis-Shield Diagnostics, Ltd. · CDD Radioassay, Vitamin B12

Cleared on Dec 19, 2011 as substantially equivalent to K062467 (Axis-Shield Diagnostics, Ltd., 2006) after a 117-day review. Its family tree reaches back 3 generations to 1999. 4 later devices descend from it.

Decided
Dec 19, 2011
Review
117 days
Class
Class II
Product code
CDD
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K993571 (1999). 4 later devices descend from it, 3 citing it directly.

  1. Root · 3 generations backK993571 Bayer Diagnostics Acs:180 VB12, Bayer Diagnostics Advia Centaue VB12Bayer Corp. · 1999
  2. 2 generations backK030655 Holotc RiaAxis-Shield Biochemicals, Asa · 2004
  3. 1 generation backK062467 Axsym Holo TC Reagent Kit, Model 3L83-20; Standard Calibrator Kit…Axis-Shield Diagnostics, Ltd. · 2006
  4. This deviceK112443 Architect Active B-12 (Holotranscobalamin)Axis-Shield Diagnostics, Ltd. · 2011
  5. Descendant · cites it directly · 1 of its ownK160757 ADVIA Centaur Active-B12 (Holotranscobalamin)(AB12) Assay, ADVIA…Axis-Shield Diagnostics Limited · 2016
  6. Descendant · cites it directly · 0 of its ownK233541 ARCHITECT Active-B12 (Holotranscobalamin)Axis-Shield Diagnostics, Ltd. · 2024
  7. Descendant · 2 generations on · 0 of its ownK172133 ADVIA Centaur Active-B12 (Holotranscobalamin) (AB12) AssayAxis-Shield Diagnostics, Ltd. · 2017
  8. Descendant · cites it directly · 0 of its ownK121946 Axis-Shield Acvtive-B12Axis-Shield Diagnostics, Ltd. · 2013

Most influential descendants

Showing 4 of 4 · See all
  • K160757ADVIA Centaur Active-B12 (Holotranscobalamin)(AB12) Assay, ADVIA Centaur…Axis-Shield Diagnostics Limited · 2016 · cites it directly1descendant
  • K233541ARCHITECT Active-B12 (Holotranscobalamin)Axis-Shield Diagnostics, Ltd. · 2024 · cites it directly0descendants
  • K172133ADVIA Centaur Active-B12 (Holotranscobalamin) (AB12) AssayAxis-Shield Diagnostics, Ltd. · 2017 · 2 generations on0descendants
  • K121946Axis-Shield Acvtive-B12Axis-Shield Diagnostics, Ltd. · 2013 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K993571Bayer Diagnostics Acs:180 VB12, Bayer Diagnostics Advia Centaue VB12Bayer Corp.1999—
−2K030655Holotc RiaAxis-Shield Biochemicals, Asa2004—
−1K062467Axsym Holo TC Reagent Kit, Model 3L83-20; Standard Calibrator Kit, Model…Axis-Shield Diagnostics, Ltd.2006—
0 (this device)K112443Architect Active B-12 (Holotranscobalamin)Axis-Shield Diagnostics, Ltd.2011—
+1K160757ADVIA Centaur Active-B12 (Holotranscobalamin)(AB12) Assay, ADVIA Centaur…Axis-Shield Diagnostics Limited2016—
+1K233541ARCHITECT Active-B12 (Holotranscobalamin)Axis-Shield Diagnostics, Ltd.2024—
+2K172133ADVIA Centaur Active-B12 (Holotranscobalamin) (AB12) AssayAxis-Shield Diagnostics, Ltd.2017—
+1K121946Axis-Shield Acvtive-B12Axis-Shield Diagnostics, Ltd.2013—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201310
201610
201710
202410
FIG. 1 — Lineage of K112443, 1999–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CDD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CDD device

  1. #1 K233541 ARCHITECT Active-B12 (Holotranscobalamin)score 8.7 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K062467Axsym Holo TC Reagent Kit, Model 3L83-20; Standard Calibrator Kit, Model 3L83-01…
Summary page 2
…ass I Classification Panel: Clinical Chemistry Product Code: JJX Legally marketed device to which equivalency is claimed: AxSYM Active-612 (HoloTO) Immunoassay (k062467) Intended Use of Device: The ARCHITECT Active-B12 (Holotranscobalamin) assay is a chemiluminescent microparticle immunoassa…
Axis-Shield Diagnostics, Ltd.2006—

What descends from it? (4)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K160757ADVIA Centaur Active-B12 (Holotranscobalamin)(AB12) Assay, ADVIA Centaur…Axis-Shield Diagnostics Limited20161
K233541ARCHITECT Active-B12 (Holotranscobalamin)Axis-Shield Diagnostics, Ltd.20240
K121946Axis-Shield Acvtive-B12Axis-Shield Diagnostics, Ltd.20130

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 12 years and passes through 3 companies; a new generation was cleared every 4.1 years on median.
  • None of the 3 ancestors has a recall.
  • Of its descendants, K160757 (Axis-Shield Diagnostics Limited, 2016) has gone furthest, with 1 descendant of its own.

How does its category compare?

All CDD devices

CDD Radioassay, Vitamin B12: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · CDD

1in 2024

2007: 12009: 12010: 12011: 32012: 32013: 12014: 22015: 12016: 22017: 12019: 22022: 12024: 1
2007high 3 (2011) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CDD

147in 2012

2011: 117 days median2012: 147 days median
2007high 147 (2012) · low 117 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CDD

1in 2021

2007: 12018: 22019: 12021: 1
2007high 2 (2018) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CDD

44in 2025

2010: 42011: 362012: 232013: 452014: 122015: 42016: 62017: 92018: 152019: 142020: 112021: 282022: 242023: 272024: 332025: 44
2007high 45 (2013) · low 0 (2007)2025

MAUDE reports naming product code CDD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—10
20080—00
20091—00
20101—04
20113117036
20123147023
20131—045
20142—012
20151—04
20162—06
20171—09
20180—215
20192—114
20200—011
20210—128
20221—024
20230—027
20241—033
20250—044
20260—0—

What is it indicated for?

The ARCHITECT Active-B12 (Holotranscobalamin) assay is a chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of Holotranscobalamin in human serum on the ARCHITECT i System. Active-B12 (Holotranscobalamin) is used as an aid in the diagnosis and treatment of vitamin B12 deficiency. The ARCHITECT Active-B12 (Holotranscobalamin) Calibrators are for the calibration of the ARCHITECT i System when used for the quantitative…

Read the full statement (105 words)

The ARCHITECT Active-B12 (Holotranscobalamin) assay is a chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of Holotranscobalamin in human serum on the ARCHITECT i System. Active-B12 (Holotranscobalamin) is used as an aid in the diagnosis and treatment of vitamin B12 deficiency.

The ARCHITECT Active-B12 (Holotranscobalamin) Calibrators are for the calibration of the ARCHITECT i System when used for the quantitative determination of Holotranscobalamin in human serum.

The ARCHITECT Active-B12 (Holotranscobalamin) Controls are for the estimation of test precision and the detection of. systematic analytical deviations of the ARCHITECT i System (reagents, calibrators and instrument) when used for the quantitative determination of Holotranscobalamin in human serum.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K112443: Architect Active B-12 (Holotranscobalamin).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K112443

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026